Osaic Holdings
PACB icon

Osaic Holdings’s Pacific Biosciences PACB Stock Holding History

Osaic Holdings’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$276K Buy
164,522
+124,231
+308% +$181K ﹤0.01% 4167
2026
Q1 		$53.2K Buy
40,291
+15,216
+61% +$27.2K ﹤0.01% 5163
2025
Q4 		$46.9K Buy
25,075
+4,877
+24% +$9.37K ﹤0.01% 5283
2025
Q3 		$25.7K Sell
20,198
-16,575
-45% -$22.4K ﹤0.01% 5769
2025
Q2 		$45.6K Sell
36,773
-664
-2% -$767 ﹤0.01% 5122
2025
Q1 		$44.2K Sell
37,437
-683
-2% -$1.05K ﹤0.01% 4812
2024
Q4 		$69.7K Sell
38,120
-49,253
-56% -$96.1K ﹤0.01% 4447
2024
Q3 		$149K Buy
87,373
+1,126
+1% +$1.85K ﹤0.01% 3900
2024
Q2 		$118K Sell
86,247
-9,476
-10% -$19.1K ﹤0.01% 4000
2024
Q1 		$359K Buy
95,723
+34,971
+58% +$205K ﹤0.01% 3209
2023
Q4 		$596K Buy
60,752
+22,011
+57% +$180K ﹤0.01% 3008
2023
Q3 		$323K Sell
38,741
-1,834
-5% -$21K ﹤0.01% 3614
2023
Q2 		$540K Sell
40,575
-1,148
-3% -$14K ﹤0.01% 3082
2023
Q1 		$483K Buy
41,723
+4,745
+13% +$47.2K ﹤0.01% 3122
2022
Q4 		$303K Buy
36,978
+24,648
+200% +$212K ﹤0.01% 3507
2022
Q3 		$72K Buy
12,330
+690
+6% +$3.96K ﹤0.01% 4633
2022
Q2 		$52K Sell
11,640
-3,212
-22% -$19.5K ﹤0.01% 4931
2022
Q1 		$1.85M Buy
14,852
+330
+2% +$3.8K ﹤0.01% 1981
2021
Q4 		$299K Buy
14,522
+6,050
+71% +$146K ﹤0.01% 3566
2021
Q3 		$216K Buy
8,472
+400
+5% +$11.9K ﹤0.01% 3830
2021
Q2 		$284K Buy
8,072
+329
+4% +$9.57K ﹤0.01% 3570
2021
Q1 		$258K Buy
7,743
+3,028
+64% +$106K ﹤0.01% 3521
2020
Q4 		$123K Buy
+4,715
New +$80.1K ﹤0.01% 3901

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Osaic Holdings's PACB Position: Q2 2026 in Review

Osaic Holdings increased its Pacific Biosciences (PACB) stake by 308% in Q2 2026, buying an estimated $181K and bringing the position to 164,522 shares worth $276K. The position accounts for ﹤0.01% of the portfolio, ranked #4167.

Osaic Holdings first reported a position in PACB in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.85M in Q1 2022. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Osaic Holdings held 164,522 shares of Pacific Biosciences worth $276K as of Q2 2026.
  • Osaic Holdings bought 124,231 Pacific Biosciences shares in Q2 2026, an estimated $181K.
  • Pacific Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4167 holding.
  • Osaic Holdings first reported a position in Pacific Biosciences in Q4 2020 and has held it in 23 quarters since.
  • Osaic Holdings's Pacific Biosciences position peaked at $1.85M in Q1 2022.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.